Dr. Josee Guindon - Faculty Page | Texas Tech University Health Sciences Center

                                  Photo of Dr. Guindon

Research Statement

The Guindon lab investigate using behavioral, pharmacological, immunohistochemical and molecular biology to better understand the different mechanism involved in pain pathways. How to modulate pain by using physiological processes as well as reference compounds and endocannabinoid modulators is one of my main interest. Indeed, the use of exercise as a physiological process to modulate pain is one of my interest. The use of different pain models such as acute, inflammatory and neuropathic pain models and the combination of known treatment with cannabinoid compounds to alleviate pain is another area of my expertise.

I have also recently investigated the physiological processes involved in kidney protection following chemotherapy treatment using different pretreatments (sodium bicarbonate, vitamin c) that seems to improve chemotherapeutic agent nephrotoxic side effects while preserving the chemotherapy-induced neuropathy. Indeed, chemotherapy-induced neuropathy is dose and time limiting. Thus, improving nephrotoxic side effects will enable us to evaluate long term neuropathic pain and study different clinically relevant treatments could alleviate chemotherapy-induced pain.

Finally, I am recently working on the determination of whether coordinated action of JNK signaling pathways is responsible for tolerance to the analgesic effects of clinically relevant compounds in inflammatory and chemotherapy-induced neuropathic pain models. The clinical implications of better understanding the different mechanisms behind analgesic tolerance is trivial for physicians and patients.

Dr. Josee Guindon, DVM,Ph.D.

Texas Center for Comparative Cancer Research Seed Grant Recipient

Awarded thTC3R Seed Grant: (PI Josee Guindon, Co-I Igor Ponomarev) "Breast Cancer cloaking effect against chemotherapy-induced peripheral neuropathy and identification of mol. targets"

Seed Grant Recipient

Awarded the GIA Collaborative Seed Grant Program in Aging: (PI Josee Guindon) "Role of mitochondrial dysfunction in changing inflammatory factors in aging mice subjected to chemotherapy-induced pain sensitivity".

(February 1, 2020-January 31, 2021) 


Josee Guindon, DVM, PhD

NIDA-1R01DA044999-01A1, (PI Josee Guindon)
“Mechanisms of cannabinoid tolerance”, 
(September 2018 - July 2023)

NIDA, 3R01DA044999-01A1S1,
(PI, Josee Guindon), NIDA Summer Research Internship Program awarded to Dr. Guindon laboratory in relation to her active R01 “Mechanisms of cannabinoid tolerance”
(June 1, 2019 - July 31, 2019)

Got Questions?

We're here to help. Contact us if you have questions.

Dr. Josee Guindon

(806) 743 - 6745